menu
    • menu

    Company profile for Synairgen

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Synairgenunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Synairgen plc / Synairgen Research Ltd Mailpoint 810 Southampton General Hospi...
    Telephone
    Telephone
    +44 (0) 23 8051 2800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.synairgen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Synairgen announces data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001
    Synairgen announces data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001

    04 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221004005650/en

    BUSINESSWIRE
    04 Oct 2022
    Share Share
    Synairgen assessing three clinical options for antiviral drug
    Synairgen assessing three clinical options for antiviral drug

    29 Sep 2022

    // PROACTIVEINVESTOR

    https://www.proactiveinvestors.co.uk/companies/news/993982/synairgen-assessing-three-clinical-options-for-antiviral-drug-993982.html

    PROACTIVEINVESTOR
    29 Sep 2022
    Share Share
    Synairgen to Present COVID Data From Phase 3 SPRINTER Study
    Synairgen to Present COVID Data From Phase 3 SPRINTER Study

    20 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220920005510/en

    BUSINESSWIRE
    20 Sep 2022
    Share Share
    Synairgen announces positive findings from the SG015 trial of SNG001
    Synairgen announces positive findings from the SG015 trial of SNG001

    07 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220907005735/en

    BUSINESSWIRE
    07 Sep 2022
    Share Share
    Synairgen announces its collaboration the UNIVERSAL trial, an study of patients
    Synairgen announces its collaboration the UNIVERSAL trial, an study of patients

    05 Sep 2022

    // SYNAIRGEN

    https://www.synairgen.com/media/company-announce-collaboration-on-universal-trial

    SYNAIRGEN
    05 Sep 2022
    Share Share
    Synairgen tests new anti-Covid drug
    Synairgen tests new anti-Covid drug

    16 May 2022

    // Chris Yandall DAILY ECHO

    https://www.dailyecho.co.uk/news/20143042.synairgen-tests-new-anti-covid-drug/

    Chris Yandall DAILY ECHO
    16 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search